OCV

Type

Venture Capital

Status

Active

Location

Los Angeles, United States

Total investments

19

Average round size

54M

Portfolio companies

13

Rounds per year

2.38

Lead investments

2

Follow on index

0.32

Exits

3

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareArtificial IntelligenceMachine LearningHealth CareWellnessIndustrialNutritionClinical TrialsPublic Safety

Summary

OCV is the famous VC, which was founded in 2016. The main department of described VC is located in the Los Angeles. The venture was found in North America in United States.

The current fund was established by Mark Yung. Besides them, we counted 1 critical employee of this fund in our database.

This OCV works on 4 percentage points more the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. When the investment is from OCV the average startup value is 100-500 millions dollars. The fund is generally included in 2-6 deals every year. The top activity for fund was in 2019. The increased amount of exits for fund were in 2019.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the OCV, startups are often financed by Secocha Ventures, Accel, Ribbit Capital. The meaningful sponsors for the fund in investment in the same round are Secocha Ventures, Ortho Vision, venBio Partners. In the next rounds fund is usually obtained by Secocha Ventures, Ortho Vision.

The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Invoice2go, Finch Therapeutics Group, Ossio. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Software, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Show more

Investor highlights

Industry focus
B2B/EnterpriseFintechProptech/Real EstateHealthcareMedtech

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
19
Lead investments
2
Exits
3
Rounds per year
2.38
Follow on index
0.32
Investments by industry
  • Health Care (6)
  • Biotechnology (6)
  • Artificial Intelligence (6)
  • Nutrition (3)
  • Wellness (3)
  • Show 33 more
Investments by region
  • United States (16)
  • Israel (3)
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Avg. valuation at time of investment
13M
Group Appearance index
1.00
Strategy success index
0.20

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Ossio 11 Mar 2019 Medical Device Early Stage Venture 22M United States, Massachusetts, Woburn
Plend 02 Nov 2022 Financial Services, FinTech, Peer to Peer, Personal Finance, Marketplace, Crowdfunding, Consumer Lending, Social Impact Early Stage Venture 54M England, London, United Kingdom
Rad AI 07 May 2024 Artificial Intelligence Early Stage Venture 50M United States, California, Berkeley

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.